The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2020

Filed:

Sep. 04, 2018
Applicant:

Physician's Seal, Llc, Boca Raton, FL (US);

Inventors:

Syed M. Shah, Boca Raton, FL (US);

Noreen Hassan, Boca Raton, FL (US);

Assignee:

Physician's Seal, LLC, Boca Raton, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/50 (2006.01); A23P 10/30 (2016.01); A23L 33/175 (2016.01); A61K 31/205 (2006.01); A61K 31/225 (2006.01);
U.S. Cl.
CPC ...
A61K 9/5073 (2013.01); A23L 33/175 (2016.08); A23P 10/30 (2016.08); A61K 9/5026 (2013.01); A61K 9/5031 (2013.01); A61K 9/5042 (2013.01); A61K 31/205 (2013.01); A61K 31/225 (2013.01); A23V 2002/00 (2013.01); A61K 9/5078 (2013.01);
Abstract

An oral controlled-release multiparticulate dosage form comprises a plurality of individually enteric coated particulates containing an L-carnitine that independently disperse in a patient's stomach after oral ingestion and travel through the stomach and past the pyloric sphincter without substantially releasing the L-carnitine in the stomach. The individual particulates contain (a) a solid core containing the L-carnitine, (b) a subcoating containing a cellulosic water soluble polymer over the core, and (c) an enteric coating over the subcoating. The dosage form may be used to treat conditions associated with a reduction of the amount of L-carnitine in the body.


Find Patent Forward Citations

Loading…